These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21325012)

  • 41. A complete course of intravenous antibiotics vs a combination of intravenous and oral antibiotics for perforated appendicitis in children: a prospective, randomized trial.
    Fraser JD; Aguayo P; Leys CM; Keckler SJ; Newland JG; Sharp SW; Murphy JP; Snyder CL; Sharp RJ; Andrews WS; Holcomb GW; Ostlie DJ; St Peter SD
    J Pediatr Surg; 2010 Jun; 45(6):1198-202. PubMed ID: 20620320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Short duration of initial intravenous treatment in 70 pediatric patients with osteoarticular infections].
    Prado S MA; Lizama C M; Peña D A; Valenzuela M C; Viviani S T
    Rev Chilena Infectol; 2008 Feb; 25(1):30-6. PubMed ID: 18273522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reappraisal of parenteral antimicrobial therapy for nontyphoidal Salmonella enteric infection in children.
    Tsai MH; Huang YC; Lin TY; Huang YL; Kuo CC; Chiu CH
    Clin Microbiol Infect; 2011 Feb; 17(2):300-5. PubMed ID: 20384700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A simple and more cost-effective antibiotic regimen for perforated appendicitis.
    St Peter SD; Little DC; Calkins CM; Murphy JP; Andrews WS; Holcomb GW; Sharp RJ; Snyder CL; Ostlie DJ
    J Pediatr Surg; 2006 May; 41(5):1020-4. PubMed ID: 16677904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ceftriaxone for the treatment of febrile episodes in nonneutropenic patients with hematooncological disease or HIV infection: comparison of outpatient and inpatient care.
    Egerer G; Goldschmidt H; Müller I; Karthaus M; Günther H; Ho AD
    Chemotherapy; 2001; 47(3):219-25. PubMed ID: 11306792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Home intravenous antibiotic therapy. A safe and effective alternative to inpatient care.
    Grayson ML; Silvers J; Turnidge J
    Med J Aust; 1995 Mar; 162(5):249-53. PubMed ID: 7891605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Once-daily ceftriaxone in the outpatient treatment of paediatric infections.
    Bradley JS
    Chemotherapy; 1991; 37 Suppl 3():3-6. PubMed ID: 1884651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children.
    Frenck RW; Nakhla I; Sultan Y; Bassily SB; Girgis YF; David J; Butler TC; Girgis NI; Morsy M
    Clin Infect Dis; 2000 Nov; 31(5):1134-8. PubMed ID: 11073741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ceftriaxone use in the emergency department: are we doing it right?
    Jain S; Sullivan K
    Pediatr Emerg Care; 2002 Aug; 18(4):259-64. PubMed ID: 12187130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serious bacterial infections in children. When can outpatient treatment be used?
    Gordon P
    Postgrad Med; 1991 Jul; 90(1):87-90. PubMed ID: 2062765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous antibiotic therapy in ambulatory pediatric patients.
    Goldenberg RI; Poretz DM; Eron LJ; Rising JB; Sparks SB
    Pediatr Infect Dis; 1984; 3(6):514-7. PubMed ID: 6514592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric intramuscular injections: do you know the procedure and complications?
    Losek JD; Gyuro J
    Pediatr Emerg Care; 1992 Apr; 8(2):79-81. PubMed ID: 1603705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of ceftriaxone by intravenous push on adverse drug reactions in the emergency department.
    Agunbiade A; Routsolias JC; Rizvanolli L; Bleifuss W; Sundaresan S; Moskoff J
    Am J Emerg Med; 2021 May; 43():245-248. PubMed ID: 32291165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prospective study of subcutaneous ceftriaxone in patients on palliative care].
    Centeno Cortés C; Galrica Neto I; Vara Hernando F
    Med Clin (Barc); 2008 Mar; 130(11):439. PubMed ID: 18394370
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of intraorganic electrophoresis in the treatment of peritonitis in children].
    Tiktins'kyĭ VS; Bodnar BM; Tloka VA; Trutiak IaV; Ungurian MG
    Klin Khir (1962); 1994; (6):10-1. PubMed ID: 7823449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effective use of once-daily ceftriaxone: overview of a symposium.
    Periti P
    Chemotherapy; 1991; 37 Suppl 3():26-7. PubMed ID: 1909230
    [No Abstract]   [Full Text] [Related]  

  • 58. Variability in Ceftriaxone Dosing Across 32 US Acute Care Children's Hospitals.
    Ferguson RA; Herigon JC; Lee BR; Nakamura MM; Newland JG
    J Pediatric Infect Dis Soc; 2021 May; 10(5):677-681. PubMed ID: 33528009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How far can the paediatric patient with a serious infection be managed as an outpatient?
    Dagan R
    J Hosp Infect; 1995 Jun; 30 Suppl():172-8. PubMed ID: 7560948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effective use of once-daily ceftriaxone in the treatment of moderate to severe infections: introduction to a symposium.
    Andriole VT
    Chemotherapy; 1991; 37 Suppl 3():1-2. PubMed ID: 1909227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.